Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis-Reference-Cited by-同舟云学术

Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis

Published:2016-06-01 Issue:6 Volume:73 Page:757
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Penkert Horst¹,Delbridge Claire²,Wantia Nina³,Wiestler Benedikt⁴,Korn Thomas⁵

Affiliation:

1. Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

2. Division of Neuropathology, Institute of Pathology, Technische Universität München, Munich, Germany

3. Institute of Microbiology, Immunology, and Hygiene, Technische Universität München, Munich, Germany

4. Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

5. Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany5Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Monitoring in Multiple Sclerosis — Efficacy and Safety;Neuroimaging Clinics of North America;2024-08

2. Infektionen und Multiple Sklerose;Fortschritte der Neurologie · Psychiatrie;2024-05-08

3. Nocardia Species;Principles and Practice of Pediatric Infectious Diseases;2023

4. Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline;Practical Neurology;2022-07-21

5. Prominent D‐dimer elevation and pretibial edema related to alemtuzumab treatment: A case report and literature review;Clinical and Experimental Neuroimmunology;2022-04-12